Canadian Wastewater Survey (CWS): Modelling Report

This document shows the current level of SARS-CoV-2 in the wastewater in cities across the country. In the plots below, the horizontal axis displays the month, and the vertical displays the wastewater signal as SARSCoV-2 genome copies per ml (gcp/ml). The green and orange threshold lines display the historical 25th and 75th percentile, respectively. Information on how these values are calculated can be seen in Appendix 2: Technical Documentation. The current level compared to historical data and trends for each city are shown in the top left corner of each plot, and the key messages highlight recent important changes in the data.

Measuring What Counts: Equity Prompts for Public Health Preparedness and Resilience

This guidance document encourages decision-making and action for pandemic preparedness and response that explicitly incorporate attention to structural and social determinants of health and address health inequities; and

Augments existing public health system resilience indicators to measure performance in addressing inequities and sustaining or enhancing equitable approaches now and in future outbreaks and pandemics.

Knowledge to Action Series Case Example Nunavik Board of Health and Social Services

As part of the NCCID and CWN Knowledge to Action Series, This case study shares the Nunavik Board of Health and Social Services (NBHSS) partnership with national and regional collaborators to pilot wastewater-based surveillance (WBS) as an innovative tool to enhance public health monitoring in remote Arctic communities.

Knowledge to Action Series Wastewater-Based Surveillance for Public Health

This document overviews the Wastewater-Based Surveillance (WBS) for Public Health Knowledge-to-Action Series.

This series is intended for public health personnel working across all levels, disciplines and jurisdictions. Some of the resources may be appropriate for sharing with community partners to strengthen learning and collaboration for building a strong monitoring and assessment system in support of community health.

Therapeutics for mpox

There are two anti-viral treatments used for smallpox that have been repurposed for mpox, tecovirimat and brincidofovir, of which only the former has been approved for clinical use in Canada.